Atlas Trials

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Clinical trial NCT00002160 · COMPLETED

Trial details

NCT number
NCT00002160
Sponsor
Neurex
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV InfectionsCancerPain
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.